What is CureMint?
CureMint operates at the intersection of healthcare technology and enterprise procurement, offering a robust platform designed to modernize the supply chain for dental practices across North America. The company addresses critical operational inefficiencies by automating purchasing workflows and providing centralized visibility into accounts payable processes. By reducing overhead costs and enhancing procurement control, CureMint enables dental organizations to optimize their financial performance. The platform is engineered to facilitate seamless integration for both staff and vendors, positioning the company as a vital infrastructure layer for modern dental group practices seeking to scale their operations through data-driven decision-making.
How much funding has CureMint raised?
CureMint has raised a total of $4.7M across 2 funding rounds:
Angel/Seed
$3.5M
Other Financing Round
$1.2M
Angel/Seed (2021): $3.5M with participation from Front Porch Ventures, Stout Street Capital, VentureSouth, and Cofounders Capital
Other Financing Round (2023): $1.2M, investors not publicly disclosed
Key Investors in CureMint
Stout Street Capital
A Denver-based venture capital firm specializing in early-stage technology companies, with a strong focus on B2B SaaS business models and post-revenue startups.
VentureSouth
An early-stage investment firm that leverages an extensive angel network to provide capital and strategic expertise to scalable technology ventures in the Southeastern United States.
Cofounders Capital
A venture capital fund dedicated to seed-stage investments, specifically targeting innovative B2B software companies located in the Southeast region.
What's next for CureMint?
With the infusion of this recent capital, CureMint is well-positioned to deepen its penetration into the North American dental market. The strategic roadmap likely involves enhancing its automated procurement tools and expanding its vendor network to provide even greater cost-saving opportunities for its clients. As the company transitions from its early-stage development into a more mature scaling phase, the focus will remain on maintaining high customer success rates and refining its B2B software architecture to meet the evolving demands of large-scale dental organizations. This financing round provides the necessary runway to solidify its competitive advantage in the dental SaaS ecosystem.
See full CureMint company page
